KDM2B Polyclonal Antibody

KDM2B Polyclonal Antibody

The KDM2B Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of KDM2B protein expression in various biological samples. This antibody is produced using a polyclonal approach, ensuring a diverse range of antibodies that target different epitopes of the KDM2B protein, thereby enhancing the sensitivity and accuracy of detection.

The KDM2B protein, also known as JHDM1B or FBXL10, is a member of the Jumonji C domain-containing histone demethylase family. It plays a crucial role in epigenetic regulation by removing methyl groups from histone H3 lysine 36 (H3K36), thereby modulating gene expression and chromatin structure. Dysregulation of KDM2B has been implicated in various diseases, including cancer, making it an important target for research and therapeutic development.

The KDM2B Polyclonal Antibody has been rigorously validated for its specificity and sensitivity in various experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits minimal cross-reactivity with other related proteins, ensuring accurate and reliable results. The antibody is compatible with a wide range of sample types, including cell lysates, tissue extracts, and formalin-fixed paraffin-embedded (FFPE) sections, allowing for versatile applications in both basic research and clinical studies.

This antibody is supplied as a liquid formulation, ready for immediate use without the need for additional reagents or preparations. It is provided in a convenient size, ensuring cost-effectiveness and minimizing wastage. The KDM2B Polyclonal Antibody is manufactured under strict quality control standards, ensuring batch-to-batch consistency and reproducibility.

In summary, the KDM2B Polyclonal Antibody is a highly specific and reliable tool for the detection and analysis of KDM2B protein expression. Its diverse antibody population, validated performance, and compatibility with various experimental techniques make it an ideal choice for researchers and clinicians studying the role of KDM2B in disease pathogenesis and therapeutic interventions.